Alembic Pharma wins USFDA nod for Prucalopride Tablets; expands gastro portfolio
Two strengths of 1 mg and 2 mg approved for US market Product equivalent to Takeda’s Motegrity; US market estimated ...
Two strengths of 1 mg and 2 mg approved for US market Product equivalent to Takeda’s Motegrity; US market estimated ...
USFDA grants final approval for Oseltamivir Phosphate for Oral Suspension, expanding Alembic Pharmaceuticals' respiratory and anti-infective product portfolio in the ...
Alembic Pharmaceuticals Limited marks entry into the US branded drug market with successful commercial rollout Pivya® (pivmecillinam) positioned as a ...
NE BUSINESS BUREAU MUMBAI, NOV 7 Alembic Pharmaceuticals Limited on Thursday announced that it has received final approval from the ...
NE BUSINESS BUREAU MUMBAI, NOV 11 Alembic Pharmaceuticals Limited on Monday announced that it has received Final Approval from the ...
NE NEWS SERVICE NEW DELHI, NOV 25 Drug firm Alembic Pharmaceuticals on Wednesday said its joint venture Aleor Dermaceuticals has ...
NE BUSINESS BUREAU NEW DELHI, NOV 9 Drug firm Alembic Pharmaceuticals on Monday said it has received tentative approval from ...
NE BUSINESS BUREAU NEW DELHI, OCT 26 Drug firm Alembic Pharmaceuticals on Monday said it has received a final nod ...
NE BUSINESS BUREAU NEW DELHI, OCT 22 Drug firm Alembic Pharmaceuticals on Thursday reported a 35.36 percent rise in consolidated ...
NE BUSINESS BUREAU NEW DELHI, OCT 16 Drug firm Alembic Pharmaceuticals on Friday said it has received approval from the ...
Email:
ne.gowri1964@gmail.com
Phone:
9643255068
Editorial and Administrative Office:
Block No 1 Flat No 4C
Wipro Street, Sholinganallur
Off Old Mabalipuram Road
Chennai 600119, Tamil nadu
96, First Floor, Srinathnagar Society,
(Landmark: Near Panchdev Mandir,
Karmacharinagar Vibhag-I),
Ghatlodia, Ahmedabad-380 061
© 2021 all right reserved by Navjeevanexpress.com. Consulted by MediaHives.com